EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Assessing medication adherence and their associated factors amongst type-2 diabetes mellitus patients of Jazan Province, Saudi Arabia: A single-center, cross-sectional study.

Amani Khardali, Nabeel Kashan Syed, Saad S Alqahtani, Marwa Qadri, Abdulkarim M Meraya, Norah Rajeh, Fatimah Aqeely, Sedan Alrajhi, Amnah Zanoom, Shahd Gunfuthi, Wahhaj Basudan, Thana K Hakami und 1 weitere

Saudi Pharmaceutical Journal · 2024-01 · 32 (1) · 101896

DOI: 10.1016/j.jsps.2023.101896 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Saudi Pharmaceutical Journal, 2024-01. Verfasst von Amani Khardali und 12 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Practice Research Unit, College of Pharmacy, Jazan University, Jizan - 45142, Jazan, Saudi Arabia. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The prevalence of type 2 diabetes mellitus (T2DM) globally is reaching epidemic proportions. By 2035, it is projected to increase to 417 million, which is of significant concern as T2DM represents the most oversized budget item in many healthcare systems, primarily due to the high rates of morbidity and mortality associated with the disease. The worldwide cost burden of T2DM has been inexorably growing. A key contributor to the remarkably high morbidity and mortality rates is poor glycemic control potentially associated with medication non-adherence.

Aim

The present research's main objective included assessing medication adherence among patients with T2DM in a single center in Jazan Province.

Methods

Three hundred nine patients with T2DM participated in a cross-sectional survey over three months (September to November 2022). The study participants comprised 50.8 % (females) and 49.2 % (males), with a mean age of 44.12 years (SD ± 12.70). A 31-item self-report questionnaire was used for data collection.

Results

Sixty-six percent of the sample were found to be adherent to their T2DM therapy. A positive association was noticed between the GMAS score and the participant's age (r = 0.24; p < 0.01). The participants' medication adherence was significantly associated with having age above 50 years (χ2 = 13.62; p = 0.001), residing in urban localities (χ2 = 21.37; p < 0.001), being married (χ2 = 12.80; p = 0.002), having glycated hemoglobin level more than 8 % (χ2 = 6.99; p = 0.03) and taking between one to three medications per day (χ2 = 17.63; p < 0.001).

Conclusion

The majority of T2DM patients in the present study were found adherent to their anti-diabetic medications, particularly older patients. Future studies should focus on exploring the reasons for the reported high adherence among older patients and non-adherence among younger patients, as this could facilitate the development of a strategy to enhance adherence.

Schlagwörter

Stichwörter der Autor:innen

Jazan ProvinceMedication adherenceSaudi ArabiaType-2 diabetes mellitus

Autor:innen und Institutionen

  • Pharmacy Practice Research Unit, College of Pharmacy, Jazan University, Jizan - 45142, Jazan, Saudi Arabia.
  • Department of Clinical Pharmacy, College of Pharmacy, Jazan University, Jizan - 45142, Jazan, Saudi Arabia.
  • Department of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha, Saudi Arabia.
  • Department of Pharmacology and Toxicology, College of Pharmacy, Jazan University, Jazan-45142, Saudi Arabia.
  • Inflammation Pharmacology and Drug Discovery Unit, Medical Research Center, Jazan University, Jazan-45142, Saudi Arabia.
  • Jazan Endocrinology and Diabetes Centre, Jizan - 82723, Jazan, Saudi Arabia.

Zitieren

APA

Khardali, A., Kashan Syed, N., Alqahtani, S. S., Qadri, M., Meraya, A. M., Rajeh, N., Aqeely, F., Alrajhi, S., Zanoom, A., Gunfuthi, S., Basudan, W., Hakami, T. K., & Abdelgadir, M. A. (2024). Assessing medication adherence and their associated factors amongst type-2 diabetes mellitus patients of Jazan Province, Saudi Arabia: A single-center, cross-sectional study. Saudi Pharmaceutical Journal, 32(1), 101896. https://doi.org/10.1016/j.jsps.2023.101896

Vancouver

Khardali A, Kashan Syed N, Alqahtani SS, Qadri M, Meraya AM, Rajeh N, et al. Assessing medication adherence and their associated factors amongst type-2 diabetes mellitus patients of Jazan Province, Saudi Arabia: A single-center, cross-sectional study. Saudi Pharmaceutical Journal. 2024;32(1):101896. doi:10.1016/j.jsps.2023.101896

BibTeX
@article{Khardali2024,
  author = {Khardali, Amani and Kashan Syed, Nabeel and Alqahtani, Saad S and Qadri, Marwa and Meraya, Abdulkarim M and Rajeh, Norah and Aqeely, Fatimah and Alrajhi, Sedan and Zanoom, Amnah and Gunfuthi, Shahd and Basudan, Wahhaj and Hakami, Thana K and Abdelgadir, Mawada A},
  title = {Assessing medication adherence and their associated factors amongst type-2 diabetes mellitus patients of Jazan Province, Saudi Arabia: A single-center, cross-sectional study},
  journal = {Saudi Pharmaceutical Journal},
  year = {2024},
  volume = {32},
  number = {1},
  pages = {101896},
  doi = {10.1016/j.jsps.2023.101896}
}
Kostenlos starten →